2023
DOI: 10.1155/2023/8571649
|View full text |Cite
|
Sign up to set email alerts
|

FTY720 Attenuates LPS-Induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis via the NF-κB and HDAC4/ATF Pathways

Abstract: Osteoclast (OC) abnormalities lead to many osteolytic diseases, such as osteoporosis, inflammatory bone erosion, and tumor-induced osteolysis. Exploring effective strategies to remediate OCs dysregulation is essential. FTY720, also known as fingolimod, has been approved for the treatment of multiple sclerosis and has anti-inflammatory and immunosuppressive effects. Here, we found that FTY720 inhibited osteoclastogenesis and OC function by inhibiting nuclear factor kappa-B (NF-κB) signaling. Interestingly, we a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…The activation of inflammatory cells is associated with various molecular structures, including cell membrane receptors for central nervous system signaling molecules, cell membrane channels, intracellular signal transduction pathways, and activation of intracellular transcription factors ( 8 ). This activation further leads to the release of proinflammatory factors, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), thereby causing neuronal damage and loss ( 9 , 10 ). Specifically, the intimate connection between inflammation and ASD can be attributed to the upregulated expression of proinflammatory factors, which closely relates to hippocampal and brain parenchymal damage in newborns.…”
Section: Introductionmentioning
confidence: 99%
“…The activation of inflammatory cells is associated with various molecular structures, including cell membrane receptors for central nervous system signaling molecules, cell membrane channels, intracellular signal transduction pathways, and activation of intracellular transcription factors ( 8 ). This activation further leads to the release of proinflammatory factors, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), thereby causing neuronal damage and loss ( 9 , 10 ). Specifically, the intimate connection between inflammation and ASD can be attributed to the upregulated expression of proinflammatory factors, which closely relates to hippocampal and brain parenchymal damage in newborns.…”
Section: Introductionmentioning
confidence: 99%